Browsing Tag
Sun Pharmaceutical Industries
24 posts
Sun Pharmaceutical (NSE: SUNPHARMA) bets $11.75bn on Organon (NYSE: OGN) to become a top global pharma player
Sun Pharma is borrowing scale to escape the generics trap. Organon could reshape its global pharma identity if execution holds.
Glenmark Pharmaceuticals (NSE: GLENMARK) launches GLIPIQ semaglutide in India at Rs 325 a week as generic GLP-1 era starts
Glenmark Pharmaceuticals launches GLIPIQ semaglutide in India from Rs 325 a week. Analysis of pricing, competition, and what it means for GLP-1 access. Read more.
Pharma stock watch: Are Indian midcaps like Glenmark better positioned than the giants?
Are Indian midcap pharma stocks like Glenmark set to outperform giants like Sun and Cipla? Explore 2025 trends, biotech bets, and market sentiment shifts.
Tata Motors, Sun Pharma, Eicher Motors lead NSE declines on March 27
Tata Motors, Sun Pharma, and other top NSE stocks fell on March 27, 2025, amid global trade concerns. Explore the factors driving market movements.
Sun Pharma introduces STARIZO to tackle drug-resistant skin infections in India
Sun Pharmaceutical Industries Limited has introduced STARIZO (Tedizolid Phosphate) to the Indian market, a novel antibacterial treatment targeting…
Sun Pharmaceutical completes merger with Taro Pharmaceutical to enhance market position
Sun Pharmaceutical Industries Limited has announced the completion of its strategic merger with Taro Pharmaceutical Industries Ltd. (NYSE:…
Sun Pharma gains Australian approval for Acne treatment Winlevi
Sun Pharmaceutical Industries Limited (Sun Pharma) has achieved a significant milestone in dermatology with the Australian Therapeutic Goods…
Sun Pharmaceutical proposes revised offer for Taro Pharmaceutical acquisition
In a notable development within the pharmaceutical industry, Sun Pharmaceutical Industries Limited has expressed a non-binding interest in…
Zydus Lifesciences, Sun Pharma to co-market Desidustat for CKD patients in India
Zydus Lifesciences Limited and Sun Pharmaceutical Industries Limited have announced a licensing agreement for the co-marketing of Desidustat,…
Sun Pharma’s CEQUA shows sustained dry eye disease improvement in Phase 4 study
Sun Pharmaceutical Industries Limited has made a significant announcement regarding its groundbreaking product, CEQUA (cyclosporine ophthalmic solution) 0.09%.…